Los Angeles Capital Management
AUPH icon

Los Angeles Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Los Angeles Capital Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.61M Sell
212,477
-61,741
-23% -$986K 0.01% 471
2026
Q1 		$4.06M Buy
274,218
+150,732
+122% +$2.2M 0.02% 374
2025
Q4 		$1.5M Buy
+123,486
New +$1.75M 0.01% 516

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Los Angeles Capital Management's AUPH Position: Q2 2026 in Review

Los Angeles Capital Management reduced its Aurinia Pharmaceuticals (AUPH) stake by 23% in Q2 2026, selling an estimated $986K and leaving 212,477 shares worth $3.61M. The position accounts for 0.01% of the portfolio, ranked #471.

Los Angeles Capital Management first reported a position in AUPH in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.06M in Q1 2026. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Los Angeles Capital Management held 212,477 shares of Aurinia Pharmaceuticals worth $3.61M as of Q2 2026.
  • Los Angeles Capital Management sold 61,741 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $986K.
  • Aurinia Pharmaceuticals made up 0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #471 holding.
  • Los Angeles Capital Management first reported a position in Aurinia Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Los Angeles Capital Management's Aurinia Pharmaceuticals position peaked at $4.06M in Q1 2026.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.